Studies have estimated that the penetrance of BRCA1 and BRCA2 gene mutations are association with the incidence of breast cancer only in 6%–8% of all breast cancer cases, and the cumulative incidence of sporadic breast cancer in approximately 90%–95% of the general population [4, 5]. This evidence concerns the gene BRCA2 and breast cancer.